Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88548146 | 8854814 | 6 | F | 20120229 | 20160829 | 20121023 | 20160912 | EXP | PHHY2012JP094207 | NOVARTIS | 65.87 | YR | F | Y | 53.00000 | KG | 20160912 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88548146 | 8854814 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 1615 | MG | Y | 22334 | 10 | MG | TABLET | QD | |||
| 88548146 | 8854814 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 1615 | MG | Y | 22334 | 10 | MG | TABLET | QD | |||
| 88548146 | 8854814 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 1615 | MG | Y | 22334 | 5 | MG | TABLET | QD | |||
| 88548146 | 8854814 | 4 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 1615 | MG | Y | 22334 | 10 | MG | TABLET | QD | |||
| 88548146 | 8854814 | 5 | SS | OCTREOTIDE. | OCTREOTIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 88548146 | 8854814 | 6 | C | KENALOG | TRIAMCINOLONE ACETONIDE | 1 | Unknown | UNK UKN, UNK | U | 0 | |||||||||
| 88548146 | 8854814 | 7 | C | AZUNOL ST | 2 | Oral | 3 DF, QD | U | 0 | 3 | DF | TABLET | QD | ||||||
| 88548146 | 8854814 | 8 | C | SUNITINIB | SUNITINIB | 1 | Unknown | 25 MG, QD | Y | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88548146 | 8854814 | 1 | Pancreatic neuroendocrine tumour |
| 88548146 | 8854814 | 5 | Pancreatic neuroendocrine tumour |
| 88548146 | 8854814 | 6 | Product used for unknown indication |
| 88548146 | 8854814 | 7 | Product used for unknown indication |
| 88548146 | 8854814 | 8 | Gastrinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88548146 | 8854814 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88548146 | 8854814 | Chest pain | |
| 88548146 | 8854814 | Cough | |
| 88548146 | 8854814 | Dyspnoea | |
| 88548146 | 8854814 | Febrile neutropenia | |
| 88548146 | 8854814 | Hepatic function abnormal | |
| 88548146 | 8854814 | Interstitial lung disease | |
| 88548146 | 8854814 | Malaise | |
| 88548146 | 8854814 | Palpitations | |
| 88548146 | 8854814 | Pleural effusion | |
| 88548146 | 8854814 | Pneumonia | |
| 88548146 | 8854814 | Pyrexia | |
| 88548146 | 8854814 | Rash | |
| 88548146 | 8854814 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88548146 | 8854814 | 1 | 201112 | 0 | ||
| 88548146 | 8854814 | 2 | 20120201 | 20120620 | 0 | |
| 88548146 | 8854814 | 3 | 20120808 | 20120917 | 0 | |
| 88548146 | 8854814 | 4 | 20120918 | 20121003 | 0 | |
| 88548146 | 8854814 | 6 | 20120229 | 0 | ||
| 88548146 | 8854814 | 7 | 20120229 | 0 |